Taken from concept to commercialization at scale, Alera’s devices provide Healthcare Professionals the ability to deliver enhanced care to alleviate patient discomfort and pain.
Explore Our Products
Over 350 million peripheral IVs are sold in the U.S. each year. Between 70-90% of hospital patients in the U.S. receive IV Therapy.
41% of a hospital’s Peripheral IV material costs are caused by unscheduled restarts.
Over 300 million peripheral intravenous catheters (PIVs) are used yearly in the United States with a failure rate of up to 69%.
50% of clinicians agree that catheter dislodgment is a significant, unaddressed issue in their facility.
41% of a hospital’s Peripheral IV material costs are caused by unscheduled restarts.
Over 300 million peripheral intravenous catheters (PIVs) are used yearly in the United States with a failure rate of up to 69%.
50% of clinicians agree that catheter dislodgment is a significant, unaddressed issue in their facility.
The future of MedTech lies in the shifts from intervention to prevention, invasive to non-invasive and hospitals to the home. Alera, is focused on devices and technologies that improve patient care, comfort and outcomes.
More About Alera
